The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration

Sponsor
Ataturk University (Other)
Overall Status
Completed
CT.gov ID
NCT02764008
Collaborator
(none)
60
1
3
3
19.9

Study Details

Study Description

Brief Summary

Percutaneous nephrolithotomy (PCNL) is a safe and effective procedure that is considered the standard treatment for large and complex renal stones. Although it has lower complication and morbidity rates than open surgery, the pain and discomfort related to a nephrostomy tube can cause distress for patients.

Managing this pain with opioids can lead to sedation, nausea, vomiting, and constipation, which defeat the purpose of this minimally invasive procedure.

Skin infiltration with bupivacaine around the nephrostomy tube is not effective. Infiltration of renal capsule has shown to facilitate painless insertion of nephrostomy tube, suggesting the role of renal capsule in pain management.

Peritubal infiltration of bupivacaine from renal capsule to the skin along the nephrostomy tract may alleviate postoperative pain. A unilateral Low thoracic paravertebral (PVB) block offers the option of providing extendable perioperative pain relief without the above side effects or the physiologic derangement associated with local anesthetics in the central neuraxial space.

The aim of this study is to determine whether ultrasound guided low thoracic paravertebral block effective post-operative analgesia as compared to peritubal infiltration analgesia in patients undergoing percutaneous nephrolithotomy.

Main outcome measures: The primary endpoint is postoperative opioid consumption. Secondary endpoints are visual analogue pain scores, opioid related side effects.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration in Patients Undergoing Percutaneous Nephrolithotomy
Study Start Date :
May 1, 2016
Actual Primary Completion Date :
Jul 1, 2016
Actual Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Low thoracic paravertebral block

T8-T9 Ultrasound guided paravertebral block with 20 ml %0,25 bupivacaine

Drug: Bupivacaine
20 ml %0,25 bupivacaine

Device: Ultrasound

Active Comparator: Peritubal infiltration

Peritubal infiltration with 20 ml %0,25 bupivacaine

Drug: Bupivacaine
20 ml %0,25 bupivacaine

No Intervention: Control Group

No drug

Outcome Measures

Primary Outcome Measures

  1. Opioid consumption [First 24 hours total opioid consumption]

Secondary Outcome Measures

  1. Visual analog pain score [postoperative first hour]

    Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at first hour postoperatively.

  2. Visual analog pain score [postoperative second hour]

    Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at second hour postoperatively.

  3. Visual analog pain score [postoperative 4th hour]

    Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 4th hour postoperatively

  4. Visual analog pain score [postoperative 8th hour]

    Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 8th hour postoperatively

  5. Visual analog pain score [postoperative 12th hour]

    Post operative pain will be evaluated with a Visual Analogue Scale (VAS)score of 0-10 (0= no pain and 10= worst imaginable pain) at 12th hour postoperatively.

  6. Visual analog pain score [postoperative 24th hour]

    Post operative pain will be evaluated with a Visual Analogue Scale (VAS)score of 0-10 (0= no pain and 10= worst imaginable pain) at 24th hour postoperatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • American Society of Anesthesiologist's physiologic state I-III patients undergoing percutaneous nephrolithotomy
Exclusion Criteria:
  • chronic pain

  • bleeding disorders

  • renal or hepatic insufficiency

  • patients on chronic non-steroidal anti-inflammatory medications

  • emergency cases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ataturk University Yakutiye Erzurum Turkey 25100

Sponsors and Collaborators

  • Ataturk University

Investigators

  • Study Director: Ali Ahiskalioglu, Ass.Prof., Ataturk University Anesthesiology and Reanimation

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ahmet Murat Yayik, MD, Ataturk University
ClinicalTrials.gov Identifier:
NCT02764008
Other Study ID Numbers:
  • AUTF ANESTHESIA2
First Posted:
May 5, 2016
Last Update Posted:
Oct 11, 2016
Last Verified:
Oct 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Ahmet Murat Yayik, MD, Ataturk University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 11, 2016